This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
price-performance: Archive
Here's What Could Help OSI (OSIS) Maintain Its Recent Price Strength
by Zacks Equity Research
OSI (OSIS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
OSISPositive Net Change
price-performance stock-price-change stock-price-movement
What Makes DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) a Good Fit for 'Trend Investing'
by Zacks Equity Research
DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
DDIPositive Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Kyocera (KYOCY) Should Keep going
by Zacks Equity Research
Kyocera (KYOCY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
KYOCYNegative Net Change
price-performance stock-price-change stock-price-movement
Barrett (BBSI) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Barrett (BBSI) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
BBSINegative Net Change
price-performance stock-price-change stock-price-movement
Euroseas Ltd. (ESEA) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Euroseas Ltd. (ESEA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
ESEANegative Net Change
price-performance stock-price-change stock-price-movement
Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Adma Biologics (ADMA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
ADMANegative Net Change
price-performance stock-price-change stock-price-movement
UniCredit S.p.A. Unsponsored ADR (UNCRY) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
UniCredit S.p.A. Unsponsored ADR (UNCRY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
UNCRYPositive Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help Spyre Therapeutics (SYRE) Maintain Its Recent Price Strength
by Zacks Equity Research
Spyre Therapeutics (SYRE) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
SYREPositive Net Change
price-performance stock-price-change stock-price-movement
Earnings Estimates Moving Higher for Protagonist Therapeutics (PTGX): Time to Buy?
by Zacks Equity Research
Protagonist Therapeutics (PTGX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
PTGXPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Can Docebo Inc. (DCBO) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Docebo Inc. (DCBO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
DCBONegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Zoom Video (ZM): Time to Buy?
by Zacks Equity Research
Zoom Video (ZM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ZMPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Monday.com (MNDY) Stock
by Zacks Equity Research
Monday.com (MNDY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MNDYPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Here's Why Momentum in Star Bulk Carriers (SBLK) Should Keep going
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Star Bulk Carriers (SBLK) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
SBLKPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Janux Therapeutics, Inc. (JANX) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Janux Therapeutics, Inc. (JANX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
JANXNegative Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help StoneX Group Inc. (SNEX) Maintain Its Recent Price Strength
by Zacks Equity Research
StoneX Group Inc. (SNEX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
SNEXNegative Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Protagonist Therapeutics (PTGX) is Your Friend, Here's Why
by Zacks Equity Research
Protagonist Therapeutics (PTGX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
PTGXPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in EuroDry (EDRY) is Your Friend, Here's Why
by Zacks Equity Research
EuroDry (EDRY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
EDRYPositive Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help Griffon (GFF) Maintain Its Recent Price Strength
by Zacks Equity Research
Griffon (GFF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
GFFNegative Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in H&E Equipment (HEES) is Your Friend, Here's Why
by Zacks Equity Research
H&E Equipment (HEES) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Navios Maritime Partners LP (NMM) Should Keep going
by Zacks Equity Research
Navios Maritime Partners LP (NMM) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
NMMNegative Net Change
price-performance stock-price-change stock-price-movement
Surging Earnings Estimates Signal Upside for Itron (ITRI) Stock
by Zacks Equity Research
Itron (ITRI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ITRINegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for Employers Holdings (EIG): Will It Gain?
by Zacks Equity Research
Employers Holdings (EIG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
EIGNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Expensify, Inc. (EXFY) Stock
by Zacks Equity Research
Expensify, Inc. (EXFY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
EXFYNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Amerisafe (AMSF) Might be Well Poised for a Surge
by Zacks Equity Research
Amerisafe (AMSF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AMSFNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for Nice (NICE): Will It Gain?
by Zacks Equity Research
Nice (NICE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
NICEPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank